stars 1 stars 2 stars 3

Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory disorders.

View Top Employees from Cellenkos, Inc.

Cellenkos, Inc. Questions

The Cellenkos, Inc. annual revenue was $6 million in 2024.

Simrit Parmar is the Founder of Cellenkos, Inc..

16 people are employed at Cellenkos, Inc..

Cellenkos, Inc. is based in Houston, Texas.

The NAICS codes for Cellenkos, Inc. are [54, 541, 325, 32541, 325414, 3254, 32].

The SIC codes for Cellenkos, Inc. are [283, 873, 87, 28].

Top Cellenkos, Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users